Key result
Tobacco smoking in India contributes to ~1.35 million annual deaths, driving cardiovascular risk.
Why the study?
Tobacco smoking is the single largest modifiable risk factor for cardiovascular disease in India, yet there is a lack of recent studies on its cardiovascular effects in the country.
Highlights the devastating impact of tobacco smoking on cardiovascular health in India and the urgent need for comprehensive control measures.
Supports intensified cessation efforts among Indian patients; leaves open optimal tobacco control policies for CV risk reduction.
Tobacco smoking is a significant public health issue in India, with approximately 29% of adults using tobacco products. It is the single largest modifiable and reversible risk factor for cardiovascular disease (CVD). Harmful chemicals in tobacco smoke contribute to CVDs, like coronary artery disease, stroke, peripheral artery disease, etc. There is a nonlinear correlation between tobacco exposure and cardiovascular risk, which is more pronounced in younger individuals. As the world’s third-largest tobacco market, India faces dire health and economic consequences, with nearly 1.35 million smoking-related deaths annually. Despite the gravity of the issue, there is a lack of recent studies on the cardiovascular effects of smoking in India. Smoking cessation is a crucial step in substantially reducing CVD risks and improving health outcomes. Comprehensive tobacco control strategies are essential to control the tobacco crisis and alleviate its impact on the healthcare system.
No takes yet. Share an insight, caveat, or question.
Ezhumalai et al. (2025) conducted a review in Cardiovascular disease. Tobacco smoking was evaluated. Tobacco smoking in India contributes to nearly 1.35 million smoking-related deaths annually, highlighting the urgent need for comprehensive tobacco control strategies to reduce cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: